Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.
Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Complement Ther Clin Pract. 2019 May;35:368-373. doi: 10.1016/j.ctcp.2019.03.009. Epub 2019 Mar 13.
BACKGROUND: and Purpose: Using of herbal medicines is common for cancer treatment. The aim of this study was to determine the prevalence, reasons, and predicting factors for the use of herbal medicines by Iranian cancer patients. MATERIALS AND METHODS: We conducted this cross-sectional study on 315 cancer patients through face-to-face interview in Kerman, Southeast of Iran, 2017. RESULTS: In total, 267 (84.1%) patients used at least one herbal medicine during chemotherapy courses, while only 42 (16.1%) patients discussed the use of herbal medicines with physicians. Living in urban regions (OR, 2.56; 95% CI, 1.30-5.05; P<0.0001) and the experience of constipation and diarrhea (OR, 2.11; 95% CI, 1.09-4.05; P = 0.02) were determined as some predicting factors for the use of herbal medicines. CONCLUSION: Our findings indicate that as herbal medicines are common among cancer patients and their use is often overlooked, physicians should pay particular attention to herbal medicines during chemotherapy.
背景与目的：在癌症治疗中，使用草药是很常见的。本研究旨在确定伊朗癌症患者使用草药的流行率、原因和预测因素。
材料与方法：我们于 2017 年在伊朗东南部克尔曼省通过面对面访谈，对 315 名癌症患者进行了这项横断面研究。
结果：共有 267 名（84.1%）患者在化疗期间至少使用了一种草药，而仅有 42 名（16.1%）患者与医生讨论过使用草药。居住在城市地区（OR，2.56；95%CI，1.30-5.05；P<0.0001）和经历便秘和腹泻（OR，2.11；95%CI，1.09-4.05；P=0.02）被确定为使用草药的一些预测因素。
结论：我们的研究结果表明，由于癌症患者中普遍使用草药，且其使用往往被忽视，因此医生在化疗期间应特别注意草药。
Complement Ther Clin Pract. 2019-3-13
Complement Ther Med. 2009-1
Br J Cancer. 2011-3-1
Complement Ther Med. 2018-10-3
Nat Prod Commun. 2011-7
BMC Complement Med Ther. 2023-2-7
BMC Complement Altern Med. 2014-1-16
J Complement Integr Med. 2018-11-3
Cureus. 2024-2-2
Pharmaceuticals (Basel). 2023-8-3
Food Sci Nutr. 2021-7-19
BMC Complement Med Ther. 2023-2-7
J Cancer Res Clin Oncol. 2023-7
Zotero 插件